Sense Diagnostics
Pre-clinicalDevelops non-invasive diagnostic technologies for neurological conditions using eye-tracking and other biomarkers.
Founded
2016
Focus
Diagnostics
About
Develops non-invasive diagnostic technologies for neurological conditions using eye-tracking and other biomarkers.
Funding History
2Total raised: $17.8M
Series A$15MUndisclosedMar 15, 2022
Seed$2.8MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2016
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile